Indiana University School of Medicine Microbiology and Immunolgy Indianapolis, Indiana
Overview The department maintains a group of approximately 35 graduate students. Typically, between 6 and 8 students are admitted each year. Their undergraduate backgrounds include degrees in chemistry, biochemistry, microbiology, and molecular and cellular biology. Recent graduates have moved on to postdoctoral research positions in academic and industrial settings. Others are primary faculty members teaching at liberal arts colleges.
The Location and Community Programs of Study and Degree Requirements During the first two years of graduate work, students take courses in an area of focus based on their research interests (immunology, pathogenesis, or cancer). This includes core courses in molecular biology and cell biology and selected courses in immunology, pathogenesis, virology, and/or cancer. Students are introduced to research opportunities in the department by a series of three laboratory rotations. In March of their first year, students select a research adviser and advisory committee and begin their thesis research project. Formal course work is typically completed by the end of the second year. At this time, students take a written and oral qualifying examination to be admitted to candidacy for an advanced degree. The remaining time in the program is spent toward developing both research and problem-solving skills. Progression to the Ph.D. normally takes four to five years. In addition to course work and research, students further develop their scientific and communication skills through their participation in supervised teaching, student seminars, journal clubs, and representation of their own research at local and national meetings. The department sponsors a weekly seminar series that, in conjunction with campuswide seminars, covers a diverse set of topics exposing students to national and international research investigators. Within the department, faculty interests are diverse, creating opportunities for a wide variety of research projects. Current topics of investigation include cancer (cancer cell biology, DNA repair, gene therapy, hematopoiesis, stem cell transplantation, tumor immunity, viral oncogenesis); immunology (autoimmunity, innate immunity, development and differentiation of immune cell function, transplantation biology); and pathogenesis (gene therapy and viral vectors, viral gene regulation, mechanisms of host-cell invasion, viral and bacterial pathogenesis). Faculty members also have affiliations with the NCI-designated Indiana University Cancer Center, Walther Oncology Center, Wells Center for Pediatric Research, and the Sexually Transmitted Disease Center and training programs in cancer, diabetes, aging, and gene transfer/gene therapy.
Facilities & Resources Expenses and Aid Financial Aid: Housing/Living Expenses: How to Apply / Application Who to Contact 317-274-7671 E-mail: rhaak@iupui.edu Faculty and Research • Janice S. Blum, Professor; Ph.D., Duke, 1984. Elucidation of the intracellular processing events and the steps that regulate antigen presentation. • Darron R. Brown, Professor; M.D., Rochester, 1979. Human papillomaviruses; epidemiology of HPV infections. • Hal E. Broxmeyer, Distinguished Professor; Ph.D., NYU, 1973. Hematopoiesis; factors regulating the self-renewal, proliferation, and differentiation of stem and progenitor cells. • Randy R. Brutkiewicz, Assistant Professor; Ph.D., Massachusetts, 1994. Assembly, trafficking, and function of nonclassical MHC Class I molecules. • Cheong-Hee Chang, Associate Professor; Ph.D., Virginia, 1990. The molecular mechanisms that initiate immune disorders and malignancies. • Tie Chen, Assistant Professor; M.D., Jiangxi Medical College (China), 1983. Signal transduction generated by interaction of Neisseria gonorrhoeae with receptors on host cells. • David W. Clapp, Professor; M.D., Indiana, 1982. Hematopoiesis; in utero marking of fetal hematopoietic stem cells; gene transfer. • Kenneth Cornetta, Professor; M.D., Albany, 1982. Retroviral vectors; gene transfer/gene therapy. • Alexander L. Dent, Assistant Professor; Ph.D., California, San Diego, 1991. Role of transcription factors in the development of the immune system and lymphoid malignancies. • Mary C. Dinauer, Professor; Ph.D., 1979, M.D., 1981, Chicago. Structure and regulation of phagocyte NADPH oxidase and role in host defense; regulation of neutrophil function by Rac GTPases; gene therapy of inherited hematopoietic disorders. • David B. Donner, Professor; Ph.D., Rensselaer, 1972. Host response to invasive stimuli; angiogenesis in the progression of cancer; signaling through nerve growth factor receptors. • Thomas A. Gardner, Assistant Professor; M.D., George Washington, 1990. Cancer gene therapy: discovery, development, modification, and testing of tumor-specific promoters and novel delivery mechanism. • Laura Haneline, Assistant Professor; M.D., Indiana, 1991. Hematopoiesis; role of Fanconi anemia proteins in protecting hematopoietic stem cells from apoptosis and malignant transformation; gene transfer/gene therapy. • Johnny J. He, Associate Professor; Ph.D., NYU, 1994. HIV pathogenesis in the central nervous system; regulation of HIV gene expression; HIV interaction with hematopoietic progenitor cells. • Soon-Cheol Hong, Assistant Professor; Ph.D., Virginia, 1987. Investigation of how the immune system recognizes and responds when microbial pathogens and cancer cells occur in the body. • Meei-Huey Jeng, Associate Professor; Ph.D., Wisconsin-Madison, 1992. Hormonal regulation of gene expression in breast cancer and normal breast. • Chinghai Kao, Associate Professor; Ph.D., Wisconsin-Madison, 1992. Tissue/tumor-specific promoter-bases gene therapy. • Mark H. Kaplan, Assistant Professor; Ph.D., Wayne State, 1992. Function of STAT proteins in the immune system. • Michael J. Klemsz, Associate Professor; Ph.D., Colorado, 1987. Regulation of gene expression in the immune system; molecular biology of ETS-domain transcription factors; antigen presentation via MHC class I molecules. • Louis M. Pelus, Associate Professor (part-time) and Associate Scientist; Ph.D., Rutgers, 1977. Mechanisms associated with how a novel chemokine rapidly induces mobilization of hematopoietic stem cells from bone marrow to peripheral blood; role of inhibitor of apoptosis proteins in cancer cell growth; progression of cells through the cell cycle. • Ann Roman, Professor; Ph.D., California, San Diego, 1973. Pathobiology of human papillomaviruses; differentiation-dependent regulation of viral gene expression; viral perturbation of cellular function; viral transformation. • Martin L. Smith, Assistant Professor; Ph.D., Emory, 1990. p53 and cancer; role of p53 in nucleotide excision repair. • Edward F. Srour, Professor; Ph.D., Illinois, 1986. Characterization and biology of human hematopoietic stem cells; transplantation. • Stanley M. Spinola, Professor; M.D., Georgetown, 1978. Pathogenesis and host response of Haemophilus ducreyi in an experimental model of human infection. • Gotz VonBulow, Assistant Professor; Ph.D., Witwatersrand (South Africa), 1994. Molecular immunology and signal transduction; role of cytokine receptors in the modulation of humoral immune responses. • David S. Wilkes, Professor; M.D., Temple, 1982. Role of accessory cells and humoral immunity in lung allograft rejection. |